医学
单变量
无线电技术
逻辑回归
接收机工作特性
单变量分析
放化疗
磁共振成像
曼惠特尼U检验
回顾性队列研究
宫颈癌
放射科
威尔科克森符号秩检验
阶段(地层学)
多元分析
放射治疗
内科学
癌症
多元统计
统计
数学
生物
古生物学
作者
Riccardo Autorino,Benedetta Gui,Giulia Panza,Luca Boldrini,D. Cusumano,Leila Russo,Alessia Nardangeli,Salvatore Persiani,Maura Campitelli,G. Ferrandina,G. Macchia,Vincenzo Valentini,Maria Antonietta Gambacorta,Roberto Manfredi
标识
DOI:10.1007/s11547-022-01482-9
摘要
The aim of this study is to determine if radiomics features extracted from staging magnetic resonance (MR) images could predict 2-year long-term clinical outcome in patients with locally advanced cervical cancer (LACC) after neoadjuvant chemoradiotherapy (NACRT).We retrospectively enrolled patients with LACC diagnosis who underwent NACRT followed by radical surgery in two different institutions. Radiomics features were extracted from pre-treatment 1.5 T T2w MR images. The predictive performance of each feature was quantified in terms of Wilcoxon-Mann-Whitney test. Among the significant features, Pearson correlation coefficient (PCC) was calculated to quantify the correlation among the different predictors. A logistic regression model was calculated considering the two most significant features at the univariate analysis showing the lowest PCC value. The predictive performance of the model created was quantified out using the area under the receiver operating characteristic curve (AUC).A total of 175 patients were retrospectively enrolled (142 for the training cohort and 33 for the validation one). 1896 radiomic feature were extracted, 91 of which showed significance (p < 0.05) at the univariate analysis. The radiomic model showing the highest predictive value combined the features calculated starting from the gray level co-occurrence-based features. This model achieved an AUC of 0.73 in the training set and 0.91 in the validation set.The proposed radiomic model showed promising performances in predicting 2-year overall survival before NACRT. Nevertheless, the observed results should be tested in larger studies with consistent external validation cohorts, to confirm their potential clinical use.
科研通智能强力驱动
Strongly Powered by AbleSci AI